Background: Serotonin, as an important neurotransmitter and signaling molecule, can affect thoracic aortic aneurysm (TAA) by regulating vascular cell proliferation, angiogenesis, and immune status. This research aimed to conduct a comprehensive analysis to pinpoint serotonin-related biomarkers in TAA and to elucidate their potential molecular mechanisms. Methods: Biomarkers were selected and validated through differential expression analysis, weighted gene co-expression network analysis (WGCNA), machine learning algorithms, and expression verification. Moreover, the constructed nomogram, enrichment analysis, immune infiltration analysis, and compound prediction validated the regulatory roles of the biomarkers in TAA. The single-cell dataset was analyzed to determine key cells and perform pseudo-time analysis. Simulated knockout of biomarkers was performed to determine their underlying functions and related pathways. Finally, reverse transcription quantitative PCR (RT-qPCR) was employed to confirm the expression levels of the biomarkers. Results: Overall, two biomarkers (CD300A and CLU) were determined to be associated with serotonin in TAA. The nomogram showed good performance in predicting TAA risk. These biomarkers were significantly enriched in the hematopoietic cell lineage and natural killer (NK) cell mediated cytotoxicity. Biomarker expression was significantly correlated with the infiltration proportions of M2 macrophages and neutrophils. The biomarkers were stably bound to tetrachlorodibenzodioxin and bisphenol A. Moreover, pseudo-time analysis demonstrated a notable correlation between biomarker expression and the differentiation status of monocytes/macrophages/dendritic cells (MonoMac/DC). Genes perturbed by knockout were enriched in the pyrimidine metabolism and RIG-I-like receptor signaling pathway. Finally, RT-qPCR validated that CLU was downregulated and CD300A was upregulated in the TAA group. Conclusions: Biomarkers (CD300A and CLU) associated with serotonin in TAA were identified, with their expression trends validated by RT-qPCR. This work provides novel bioinformatic insights, and direct functional experiments are required to support future therapeutic development for TAA.
We developed a multi-channel and multilayered polydimethylsiloxane (PDMS) microfluidic platform that integrates cyclic mechanical stimulation, independent reagent delivery, and real-time optical observation within a single device. The platform employs a four-layer architecture comprising a pneumatic valve control layer, an observation channel for cell culture and imaging (24 mm × 4 mm), a medium perfusion layer with independent inlet ports, and a vacuum actuation layer that deforms a 200 μm PDMS membrane under −20 kPa cyclic pressure at 1 Hz. Cyclic membrane strain of 10% was calibrated using fluorescent bead tracking and image analysis. Finite element analysis based on nonlinear Föppl–von Kármán plate theory confirmed that the central cell culture region (60% of membrane area) exhibits a mean von Mises strain of 14.2% with a uniformity of 81.3% (CV = 18.7%), validating relatively uniform mechanical stimulation across the culture surface. As a proof-of-concept, human aortic smooth muscle cells (CRL-1999) cultured under cyclic strain showed significant upregulation of HIF-1 expression (2.5-fold, ) and pronounced F-actin stress fiber alignment visualized by fluorescence microscopy, confirming the platform’s capability for mechanotransduction studies and real-time cellular observation. The multi-channel architecture enables multi-condition parallel testing by simultaneously introducing different reagent concentrations through independent inlet ports while maintaining identical mechanical parameters across all channels, providing a versatile tool for systematic investigation of cellular responses under controlled biomechanical conditions.